
table of contents
This week's psychedelic articles
概況
This week,サイケデリック医療の「臨床実装」と「規制」の動きが目立ちました。ニュージーランドでMDMA処方の実務が前進する一方、米国ではDEAによる緊急指定をめぐる議論が再燃。米国FDAの承認を見据えた安全管理(REMS)への関心も高まっています。投資・提携などビジネス面の具体的発表は、今回の収集素材では確認できませんでした。
Research and clinical implementation
- As FDA approval becomes more likely, the importance of "REMS (Risk Assessment and Mitigation Strategy)" in designing treatment delivery practices has been highlighted. While details are still uncertain, it has been indicated that REMS may play a significant role as an additional safety measure that will influence on-site implementation after approval.サイケデリックThis is a topic that could affect the speed at which treatments become available and the hurdles to providing them.Referrer
Regulation/Policy
- New Zealand regulators have ordered two psychiatrists in the country to focus on PTSD.MDMAThe prescription and administration of the drug have been approved. This is noteworthy as a practical approval step at the national level and is expected to have repercussions in future case accumulation and consideration of system operation.Referrer
- In the United States, reports of the DEA's move to temporarily place new opioid compounds (such as mitradinin pseudoindoxyl, MGM-15, and MGM-16) on Schedule I of the Controlled Substances Act have drawn criticism of the use of its emergency designation authority. Experts have expressed concerns that the ban is being implemented without demonstrating an actual imminent threat, and that it relies on "inferences of similarity." This raises questions about the balance between research and regulation in overall drug policy.Referrer
Business
- The collected materials did not contain any specific information regarding fundraising, partnerships, or new announcements from listed companies. Clinical implementation and regulatory advancements (REMS design, development of prescription systems) may have ripple effects on delivery costs and business models in the medium to long term, and may therefore be linked to future company announcements.ReferrerReferrer
Market trend
- While no new market data has been disclosed on a materials basis, the design of REMS and the direction of regulations in various countries remain points of interest as they will influence market formation through insurance reimbursement, requirements for service providers, and the speed of implementation.ReferrerReferrerReferrer
Three key points to watch out for this week
- For PTSD in New ZealandMDMAPrescription and administration of the drug become possible. This represents a step forward in on-site implementation.Referrer
- REMS in the United StatesサイケRenewed attention is being paid to the potential impact on the delivery model of derrick therapy. The focus is now on designing post-approval operational procedures.Referrer
- The emergency designation of the DEA has sparked debate about the relationship between research and policy. The balance between evidence and regulatory authority is being put to the test.Referrer

![Mail-order product: MDMA × MM Analog [For Research Use]](https://www.thch-vape.shop/html/user_data/assets/img/products/213_250x250.webp)


